Simple detection and monitoring of viral pathogens for challenging infectious disease research
Targeted next-generation sequencing (NGS) is a rapid and accurate solution for viral genomes, suitable for viral typing, epidemiological studies, and disease surveillance using archived samples from viral investigations.
Our viral typing NGS solutions provide ultra-high sensitivity, scalability, and rapid turnaround time, which are all vital to viral monitoring and investigation research.
Ion Torrent NGS technology is based on ultrahigh-multiplex PCR, the same technology that has enabled public health agencies to closely monitor viral infections.
- Low input requirements—requires as little as 1 ng of input DNA to target regions of interest
- Fast turnaround time and automation—minimize hands-on time with automated DNA-to-insights NGS workflow, enabling you to get data from your precious samples in less than 24 hours
- Accuracy of variants
- Scalable—wide application breadth and throughput capability, all on a single platform
- Flexible panel design options—order NGS research panels for infectious diseases such as coronavirus, ebola, zika, CMV, HIV, and HCV, or use the Ion AmpliSeq Designer tool at ampliseq.com to configure your own
Featured solution: One assay surveying the complete SARS-CoV-2 genome for epidemiological investigation
The Ion AmpliSeq SARS-CoV-2 Research Panel enables complete genome sequencing and epidemiological studies with >99% coverage. Deliver highly accurate coronavirus typing in under a day. Manual and automated workflow configurations are available.
The simplest and fastest targeted NGS workflow for infectious disease research
With Ion Torrent targeted NGS, easily go from DNA to data in less than 24 hours with ~45 minutes of hands-on time. Ion AmpliSeq libraries are prepared manually or with the Ion Chef System. Libraries are then placed in the Ion Chef System for emulsion PCR, enrichment, and loading onto Ion S5 Chips.
Featured panels for infectious disease research
A major challenge for microbiologists and virologists is the prediction of patterns of evolution and emergence of disease agents. RNA viruses share the biological feature of high genetic variability, which causes them to appear as clouds of mutants. Viral variants also emerge through antigenic shift within animal reservoirs like bats, snakes, pigs, and birds.
Our Ion AmpliSeq panels are based on ultrahigh-multiplex PCR, the same technology that has enabled public health agencies to closely monitor viral infections.
A few of our NGS research panels for infectious disease research are highlighted below:
Coronavirus (SARS-CoV-2) research
- Complete viral genome sequencing and variant detection of SARS-CoV-2 with >99% coverage
Zika virus (ZIKV)
- >95% coverage of ZIKV genome with amplicon-based approach1
Human papillomaviruses (HPV)
- Complete genome sequencing of HPV with up to 99% coverage2
- Amplicon lengths up to 375 bp
- The Ion AmpliSeq Ebola Research Panel targets 99.49% of the Ebola virus (EBOV) genome with 150 amplicons
Human immunodeficiency virus (HIV) early access
- One assay surveying HIV genome for drug resistance mutations
- Available in 1- and 2-pool with amplicon lengths up to 400 bp
- Genes covered: protease, reverse transcriptase, RNase, and integrase
1. Grubaugh ND, et al. Genomic epidemiology reveals multiple introductions of Zika virus into the United States. Nature. 2017 Jun 15;546(7658):401-405.
2. Cullen M, et al. Deep sequencing of HPV16 genomes: A new high-throughput tool for exploring the carcinogenicity and natural history of HPV16 infection. Papillomavirus Res. 2015 Dec 1;1:3-11.
For Research Use Only. Not for use in diagnostic procedures.